PHS
PFM Health Sciences Portfolio holdings
AUM
$1.15B
This Quarter Return
+6.95%
1 Year Return
+21.39%
3 Year Return
+130.75%
5 Year Return
+265.32%
10 Year Return
+1,236.5%
AUM
$1.74B
AUM Growth
-$91.6M
(-5%)
Cap. Flow
-$195M
Cap. Flow
% of AUM
-11.21%
Top 10 Holdings %
Top 10 Hldgs %
50.56%
Holding
88
New
12
Increased
13
Reduced
23
Closed
11
Top Buys
| 1 |
Inspire Medical Systems
INSP
|
$20.8M |
| 2 |
Acadia Healthcare
ACHC
|
$16.9M |
| 3 |
Ascendis Pharma
ASND
|
$13.6M |
| 4 |
SPDR S&P Biotech ETF
XBI
|
$12M |
| 5 |
Waters Corp
WAT
|
$11M |
Top Sells
| 1 |
Centene
CNC
|
$39.7M |
| 2 |
DexCom
DXCM
|
$26.2M |
| 3 |
Edwards Lifesciences
EW
|
$23.1M |
| 4 |
Arcellx
ACLX
|
$21M |
| 5 |
Boston Scientific
BSX
|
$20.1M |
Sector Composition
| 1 | Healthcare | 97.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CNTA
51
Centessa Pharmaceuticals
CNTA
$2.13B
| $4.3M | 0.24% |
269,158
-366,485
| -58% | -$5.86M |
|
52
Veeva Systems
VEEV
$44.4B
| $4.04M | 0.23% |
+19,259
| New | +$4.04M |
|
|
LBPH
53
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
| $3.79M | 0.21% |
+113,711
| New | +$3.79M |
|
54
Ocular Therapeutix
OCUL
$2.25B
| $3.5M | 0.2% |
+402,843
| New | +$3.5M |
|
55
Immunovant
IMVT
$2.91B
| $3.5M | 0.2% |
122,701
-349,839
| -74% | -$9.97M |
|
56
Cullinan Oncology
CGEM
$456M
| $3.06M | 0.17% |
182,810
-113,226
| -38% | -$1.9M |
|
57
Pulmonx
LUNG
$67.6M
| $3.06M | 0.17% |
+368,929
| New | +$3.06M |
|
58
PMV Pharmaceuticals
PMVP
$82.1M
| $3M | 0.17% |
2,011,040
+735,578
| +58% | +$1.1M |
|
|
CMPS
59
Compass Pathways
CMPS
$452M
| $2.84M | 0.16% |
451,267
-638,325
| -59% | -$4.02M |
|
60
IO Biotech
IOBT
$115M
| $2.46M | 0.14% |
2,341,107
| – | – |
|
61
Capricor Therapeutics
CAPR
$287M
| $2.32M | 0.13% |
+152,779
| New | +$2.32M |
|
62
Metagenomi
MGX
$67.2M
| $2.24M | 0.13% |
1,034,002
-233,000
| -18% | -$506K |
|
63
ARK Genomic Revolution ETF
ARKG
$1.05B
| $2.23M | 0.13% |
+86,934
| New | +$2.23M |
|
64
Inhibrx
INBX
$403M
| $2.12M | 0.12% |
135,546
| – | – |
|
65
Generation Bio
GBIO
$40.3M
| $1.95M | 0.11% |
78,791
| – | – |
|
66
Sagimet Biosciences
SGMT
$239M
| $1.8M | 0.1% |
649,006
| – | – |
|
67
Celldex Therapeutics
CLDX
$1.57B
| $1.77M | 0.1% |
52,120
| – | – |
|
68
Iovance Biotherapeutics
IOVA
$800M
| $1.24M | 0.07% |
132,152
-20,643
| -14% | -$194K |
|
|
BOLD
69
Boundless Bio
BOLD
$25.7M
| $835K | 0.05% |
240,513
+100,000
| +71% | +$347K |
|
|
VERV
70
DELISTED
Verve Therapeutics
VERV
| $610K | 0.03% |
+125,999
| New | +$610K |
|
71
uniQure
QURE
$954M
| $600K | 0.03% |
121,628
-152,912
| -56% | -$754K |
|
|
TSBX
72
DELISTED
Turnstone Biologics
TSBX
| $519K | 0.03% |
932,348
| – | – |
|
|
73
Centene
CNC
$14.8B
| – | – |
-598,513
| Closed | -$39.7M |
|
74
Apellis Pharmaceuticals
APLS
$3.51B
| – | – |
-82,952
| Closed | -$3.18M |
|
|
75
DexCom
DXCM
$30.9B
| – | – |
-231,007
| Closed | -$26.2M |
|